Pharma Penny Stock Under Rs 55 in Focus After Receiving GAIN Certification; Complete Details Inside
From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent.
Today, shares of Sigachi Industries Ltd gained 1.50 per cent to Rs 51.30 per share from its previous closing of Rs 50.54 per share. The company has a market cap of over Rs 1,600 crore and has delivered good profit growth of 25 per cent CAGR over the last 5 years.
Sigachi Industries Limited is proud to announce its recent achievement of GAIN (Global Alliance for Improved Nutrition) audit certification. By meeting the stringent standards and guidelines set by GAIN, Sigachi reinforces its dedication to producing high-quality, safe, and nutritionally enriched products that cater to the evolving needs of consumers worldwide. This certification underscores Sigachi's shared belief with GAIN that everyone globally should have access to nutritious, safe, and affordable food.
Sigachi's range of Vitamin and Mineral Premixes, known as BaseBlend, will now be supplied to customers globally with the highest quality assurance. The Global Premix Industry, valued at USD 5.1 Billion in 2021, is projected to reach USD 6.2 Billion by 2026, exhibiting a CAGR of 4.4 per cent. This market is experiencing substantial growth driven by shifting consumer preferences towards convenient foods and evolving dietary and lifestyle habits. With growing health consciousness, the demand for fortified foods and beverages is rapidly increasing in both developed and developing nations. Fortification of Food with Nutrients is a global phenomenon, with over 97 countries worldwide implementing mandatory fortification programs. With a 9000 MT/installed capacity certified by GAIN and a global presence across 65 countries (in Food and Pharma Excipients), Sigachi is poised to effectively cater to the global premix industry with its renowned BaseBlend brand.
Commenting on this development, Amit Raj Sinha, Managing Director and CEO of Sigachi Industries Limited stated “The GAIN certification is a testament to the hard work and dedication of our team in ensuring that our products meet the highest standards of safety, quality, and nutritional value. We are proud to be part of a global movement focused on food security and fortification, and we remain committed to advancing the health and well-being of consumers worldwide."
DSIJ’s 'Tiny Treasure' service recommends researched Small-Cap stocks with Inherent Growth Potential. If this interests you, do download the service details here.
About the Company
Sigachi Industries Limited, a publicly traded pharmaceutical company listed on NSE and BSE, is a global leader in providing high-quality excipients, vitamin-mineral nutrient blends, APIs, and O&M services. With over 35 years of industry expertise, Sigachi has built a strong reputation as a trusted partner for pharmaceutical and nutraceutical companies worldwide. They specialize in innovative solutions for food stability, fortification, and nutrition, offering tailored blends of vitamins, minerals, and other ingredients to meet the evolving needs of consumers. By utilizing advanced technologies like blending, encapsulation, and spray drying, Sigachi empowers food manufacturers to create products with superior taste, quality, and nutritional value, contributing to a healthier and happier world.
The company announced positive Quarterly Results (Q2FY25) and half-yearly results (FY24) for the financial year 2024. According to quarterly results, revenue increased by 38.10 per cent to Rs 137 crore, EBITDA increased by 36.91 per cent to Rs 29.3 crore and PAT increased by 39.07 per cent to Rs 21 crore in Q2FY25 compared to Q2FY24. In its half-yearly results, revenue increased by 26.53 per cent to Rs 232.7 crore, EBITDA increased by 33.33 per cent to Rs 50.40 crore and PAT increased by 29.61 per cent to Rs 33.7 crore in H1FY25 compared to H1FY24.
From Rs 43.42 per share (52-week low) to Rs 51.30 per share, the stock is up by 18.15 per cent. Investors should keep an eye on this small-cap pharma stock.
Disclaimer: The article is for informational purposes only and not investment advice.